Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth Russell

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Journal of the American College of Emergency Physicians Open|February 22, 2024
Effectiveness of subcutaneous monoclonal antibody treatment in emergency department outpatients with COVID-19Sarah K Wendel, Adane F Wogu, Nichole E Carlson, et al.
Journal of the American Medical Informatics Association : JAMIA|May 11, 2021
Real-time electronic health record mortality prediction during the COVID-19 pandemic: a prospective cohort studyPeter D Sottile, David Albers, Peter E DeWitt, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2021
Real-Time Electronic Health Record Mortality Prediction During the COVID-19 Pandemic: A Prospective Cohort StudyPeter D Sottile, David Albers, Peter E DeWitt, et al.
The Journal of Infectious Diseases|May 16, 2022
Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 OutpatientsNeil R Aggarwal, Laurel E Beaty, Tellen D Bennett, et al.
BMC Infectious Diseases|November 7, 2022
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatientsDavid J Douin, Adane F Wogu, Laurel E Beaty, et al.
Medrxiv : the Preprint Server for Health Sciences|April 12, 2022
Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 OutpatientsNeil R Aggarwal, Laurel E Beaty, Tellen D Bennett, et al.
Medrxiv : the Preprint Server for Health Sciences|January 19, 2022
Real World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 OutpatientsMatthew K Wynia, Laurel E Beaty, Tellen D Bennett, et al.
Medrxiv : the Preprint Server for Health Sciences|August 29, 2022
Risk Factors Associated with Post-Acute Sequelae of SARS-CoV-2 in an EHR Cohort: A National COVID Cohort Collaborative (N3C) Analysis as part of the NIH RECOVER programElaine Hill, Hemal Mehta, Suchetha Sharma, et al.
Chest|November 28, 2022
Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 OutpatientsMatthew K Wynia, Laurel E Beaty, Tellen D Bennett, et al.
Lancet Regional Health. Americas|March 19, 2024
Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort studyNeil R Aggarwal, Laurel E Beaty, Tellen D Bennett, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of the American College of Emergency Physicians Open|February 22, 2024
Effectiveness of subcutaneous monoclonal antibody treatment in emergency department outpatients with COVID-19Sarah K Wendel, Adane F Wogu, Nichole E Carlson, et al.
Journal of the American Medical Informatics Association : JAMIA|May 11, 2021
Real-time electronic health record mortality prediction during the COVID-19 pandemic: a prospective cohort studyPeter D Sottile, David Albers, Peter E DeWitt, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2021
Real-Time Electronic Health Record Mortality Prediction During the COVID-19 Pandemic: A Prospective Cohort StudyPeter D Sottile, David Albers, Peter E DeWitt, et al.
The Journal of Infectious Diseases|May 16, 2022
Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 OutpatientsNeil R Aggarwal, Laurel E Beaty, Tellen D Bennett, et al.
BMC Infectious Diseases|November 7, 2022
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatientsDavid J Douin, Adane F Wogu, Laurel E Beaty, et al.
Medrxiv : the Preprint Server for Health Sciences|April 12, 2022
Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 OutpatientsNeil R Aggarwal, Laurel E Beaty, Tellen D Bennett, et al.
Medrxiv : the Preprint Server for Health Sciences|January 19, 2022
Real World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 OutpatientsMatthew K Wynia, Laurel E Beaty, Tellen D Bennett, et al.
Medrxiv : the Preprint Server for Health Sciences|August 29, 2022
Risk Factors Associated with Post-Acute Sequelae of SARS-CoV-2 in an EHR Cohort: A National COVID Cohort Collaborative (N3C) Analysis as part of the NIH RECOVER programElaine Hill, Hemal Mehta, Suchetha Sharma, et al.
Chest|November 28, 2022
Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 OutpatientsMatthew K Wynia, Laurel E Beaty, Tellen D Bennett, et al.
Lancet Regional Health. Americas|March 19, 2024
Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort studyNeil R Aggarwal, Laurel E Beaty, Tellen D Bennett, et al.
Pageof 5